Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-18

FDA Approved: OXALIPLATIN — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approves the supplemental application for Oxaliplatin from Sandoz Inc. This action authorizes the changes described in the supplement to the product's appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OXALIPLATIN (Oxaliplatin)

Snippet

SUPPL AP for OXALIPLATIN (OXALIPLATIN)